Search for a report

ASIA-PACIFIC COUGH SYRUP MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • ASIA-PACIFIC COUGH SYRUP MARKET FORECAST 2021-2028

ASIA-PACIFIC COUGH SYRUP MARKET FORECAST 2021-2028

The Asia-Pacific cough syrup market is anticipated to develop with a CAGR of 3.29% during the projected period of 2021 to 2028. The influence of diverse economic, social, and environmental factors on respiratory health, the increasing geriatric population, and rising rates of air pollution and greenhouse farming are among the key factors associated with the regional market’s growth.

ASIA-PACIFIC COUGH SYRUP MARKET FORECAST 2021-2028

Asia Pacific Cough Syrup Market by Product Type (Cough Suppressants/antitussives, Combination Medications, Expectorants) Market by Age Group (Adult, Pediatric) Market by Distribution Channels (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) by Geography.

Request free sample

The Asia-Pacific cough syrup market is anticipated to develop with a CAGR of 3.29% during the projected period of 2021 to 2028. The influence of diverse economic, social, and environmental factors on respiratory health, the increasing geriatric population, and rising rates of air pollution and greenhouse farming are among the key factors associated with the regional market’s growth.asia-pacific-cough-syrup-market

To learn more about this report, request a free sample copy

The Asia-Pacific cough syrup market growth evaluation entails the assessment of Vietnam, Thailand, South Korea, Japan, China, India, Indonesia, Australia & New Zealand, and the rest of the Asia-Pacific. Chronic obstructive pulmonary disease (COPD) is a widespread disease in China, with biomass fuels and smoking representing the leading causes of the condition. Besides, COPD is the fifth largest cause of mortality in the country. As per industry sources, China has more than 320 million smokers, accounting for nearly 4% and 67% of the total adult female and male population, respectively.

As the Japanese population continues to age, the number of patients with respiratory failure, lung cancer, pneumonia, and asthma observes a subsequent increase, as well. In recent years, lung cancer has consistently ranked first in men for malignant tumors. As the top cause of death in Japan, the condition depicts a rising trend in both women as well as men. Therefore, these factors are expected to drive the cough syrup market growth in the Asia-Pacific over the forecasting years.

Cipla Limited, headquartered in India, is an international pharmaceutical company providing active pharmaceutical ingredients and formulations across various therapeutic areas such as children’s health, cardiovascular, women’s health, cosmeceuticals, dermatology, HIV-AIDS, infectious diseases and critical care, diabetes, hepatitis, oncology, osteoporosis, respiratory, neurosciences, ophthalmology, and others. The company also distributes veterinary products, including anti-inflammatories, anti-thyroids, anti-infectives, immunosuppressants, nutraceuticals, parasiticides, and feed additives for animals.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • RISING GERIATRIC POPULATION
        • INCREASE IN CHRONIC RESPIRATORY DISEASES
      • KEY RESTRAINTS
        • OVERDOSE RISKS ASSOCIATED WITH COUGH SYRUP
        • GOVERNMENT REGULATIONS AND RESTRICTIONS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON COUGH SYRUP MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY PRODUCT TYPE
      • COUGH SUPPRESSANTS/ANTITUSSIVES
      • COMBINATION MEDICATIONS
      • EXPECTORANTS
    3. MARKET BY AGE GROUP
      • ADULT
      • PEDIATRIC
    4. MARKET BY DISTRIBUTION CHANNELS
      • RETAIL PHARMACY
      • HOSPITAL PHARMACY
      • ONLINE PHARMACY
    5. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY DRIVERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • INDONESIA
          • THAILAND
          • VIETNAM
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PARTNERSHIPS & AGREEMENTS
      • COMPANY PROFILES
        • ABBOTT LABORATORIES
        • ACELLA PHARMACEUTICALS LLC
        • ASTRAZENECA PLC
        • CIPLA LIMITED
        • DABUR INDIA LTD
        • GLAXOSMITHKLINE PLC
        • GLENMARK PHARMACEUTICAL LIMITED
        • JOHNSON & JOHNSON
        • MERCK KGAA
        • NOVARTIS INTERNATIONAL AG
        • PFIZER INC
        • PROCTOR & GAMBLE CO (P&G)
        • RECKITT BENCKISER GROUP PLC
        • SANOFI SA
        • THE HIMALAYA DRUG COMPANY

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – COUGH SYRUP

    TABLE 2: THE COUNTRIES WITH THE LARGEST PERCENTAGE OF TOTAL POPULATION OVER 65 YEARS, IN 2020

    TABLE 3: ASIA-PACIFIC COUGH SYRUP MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 4: ASIA-PACIFIC COUGH SYRUP MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 5: ASIA-PACIFIC COUGH SYRUP MARKET, BY AGE GROUP, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 6: ASIA-PACIFIC COUGH SYRUP MARKET, BY AGE GROUP, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 7: ASIA-PACIFIC COUGH SYRUP MARKET, BY DISTRIBUTION CHANNELS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 8: ASIA-PACIFIC COUGH SYRUP MARKET, BY DISTRIBUTION CHANNELS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 9: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 10: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 11: KEY PLAYERS IN ASIA-PACIFIC COUGH SYRUP MARKET

    TABLE 12: LIST OF MERGERS & ACQUISITIONS

    TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: ASIA-PACIFIC COUGH SYRUP MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2020

    FIGURE 6: ASIA-PACIFIC COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS/ANTITUSSIVES, 2021-2028 (IN $ MILLION)

    FIGURE 7: ASIA-PACIFIC COUGH SYRUP MARKET, BY COMBINATION MEDICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 8: ASIA-PACIFIC COUGH SYRUP MARKET, BY EXPECTORANTS, 2021-2028 (IN $ MILLION)

    FIGURE 9: ASIA-PACIFIC COUGH SYRUP MARKET, GROWTH POTENTIAL, BY AGE GROUP, IN 2020

    FIGURE 10: ASIA-PACIFIC COUGH SYRUP MARKET, BY ADULT, 2021-2028 (IN $ MILLION)

    FIGURE 11: ASIA-PACIFIC COUGH SYRUP MARKET, BY PEDIATRIC, 2021-2028 (IN $ MILLION)

    FIGURE 12: ASIA-PACIFIC COUGH SYRUP MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNELS, IN 2020

    FIGURE 13: ASIA-PACIFIC COUGH SYRUP MARKET, BY RETAIL PHARMACY, 2021-2028 (IN $ MILLION)

    FIGURE 14: ASIA-PACIFIC COUGH SYRUP MARKET, BY HOSPITAL PHARMACY, 2021-2028 (IN $ MILLION)

    FIGURE 15: ASIA-PACIFIC COUGH SYRUP MARKET, BY ONLINE PHARMACY, 2021-2028 (IN $ MILLION)

    FIGURE 16: ASIA-PACIFIC COUGH SYRUP MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 17: CHINA COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 18: JAPAN COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 19: INDIA COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 20: SOUTH KOREA COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 21: INDONESIA COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 22: THAILAND COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 23: VIETNAM COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 24: AUSTRALIA & NEW ZEALAND COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 25: REST OF ASIA-PACIFIC COUGH SYRUP MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY DRIVERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • INDONESIA
          • THAILAND
          • VIETNAM
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
    1. MARKET BY PRODUCT TYPE
      • COUGH SUPPRESSANTS/ANTITUSSIVES
      • COMBINATION MEDICATIONS
      • EXPECTORANTS
    2. MARKET BY AGE GROUP
      • ADULT
      • PEDIATRIC
    3. MARKET BY DISTRIBUTION CHANNELS
      • RETAIL PHARMACY
      • HOSPITAL PHARMACY
      • ONLINE PHARMACY

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now